Literature DB >> 15643014

Evaluation of a West Nile virus immunoglobulin A capture enzyme-linked immunosorbent assay.

Harry E Prince1, Mary Lapé-Nixon.   

Abstract

An in-house-developed enzyme-linked immunosorbent assay detected West Nile virus (WNV) immunoglobulin A (IgA) in 65 of 68 sera from WNV-infected patients; 40 of 63 WNV IgM-positive, IgG-negative serum or plasma specimens; 65 of 67 WNV IgM-positive, IgG-positive specimens; 0 of 70 WNV IgM-negative, IgG-negative specimens; and 0 of 64 archived blood donation sera. WNV IgA is thus highly prevalent among WNV-infected patients and typically appears after WNV IgM but before WNV IgG.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15643014      PMCID： PMC540217          DOI： 10.1128/CDLI.12.1.231-233.2005

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  11 in total

1.  Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay.

Authors:  A J Johnson; D A Martin; N Karabatsos; J T Roehrig
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

2.  Neutralizing antibody responses in the major immunoglobulin classes to yellow fever 17D vaccination of humans.

Authors:  T P Monath
Journal:  Am J Epidemiol       Date:  1971-02       Impact factor: 4.897

3.  Serum and cerebrospinal fluid immunoglobulins M, A, and G in Japanese encephalitis.

Authors:  X Y Han; Q W Ren; Z Y Xu; T F Tsai
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

4.  Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection.

Authors:  P Koraka; C Suharti; T E Setiati; A T Mairuhu; E Van Gorp; C E Hack; M Juffrie; J Sutaryo; G M Van Der Meer; J Groen; A D Osterhaus
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  Immunoglobulin A-specific capture enzyme-linked immunosorbent assay for diagnosis of dengue fever.

Authors:  A Talarmin; B Labeau; J Lelarge; J L Sarthou
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

Review 6.  West Nile virus: a primer for the clinician.

Authors:  Lyle R Petersen; Anthony A Marfin
Journal:  Ann Intern Med       Date:  2002-08-06       Impact factor: 25.391

7.  Laboratory-acquired West Nile virus infections--United States, 2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-12-20       Impact factor: 17.586

8.  Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies.

Authors:  Wayne R Hogrefe; Ronald Moore; Mary Lape-Nixon; Michael Wagner; Harry E Prince
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

9.  Utility of the focus technologies west nile virus immunoglobulin M capture enzyme-linked immunosorbent assay for testing cerebrospinal fluid.

Authors:  Harry E Prince; Mary Lape'-Nixon; Ronald J Moore; Wayne R Hogrefe
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

10.  Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases.

Authors:  John T Roehrig; Denis Nash; Beth Maldin; Anne Labowitz; Denise A Martin; Robert S Lanciotti; Grant L Campbell
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883
View more
  7 in total

1.  Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.

Authors:  Harry E Prince; Leslie H Tobler; Mary Lapé-Nixon; Gregory A Foster; Susan L Stramer; Michael P Busch
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

2.  Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus.

Authors:  P N Levett; K Sonnenberg; F Sidaway; S Shead; M Niedrig; K Steinhagen; G B Horsman; M A Drebot
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

3.  Persistence of West Nile virus-specific antibodies in viremic blood donors.

Authors:  Harry E Prince; Leslie H Tobler; Cindy Yeh; Nelly Gefter; Brian Custer; Michael P Busch
Journal:  Clin Vaccine Immunol       Date:  2007-07-25

4.  Geographic factors contributing to a high seroprevalence of West Nile virus-specific antibodies in humans following an epidemic.

Authors:  Beth K Schweitzer; Wayne L Kramer; Anthony R Sambol; Jane L Meza; Steven H Hinrichs; Peter C Iwen
Journal:  Clin Vaccine Immunol       Date:  2006-03

5.  The Application and Interpretation of IgG Avidity and IgA ELISA Tests to Characterize Zika Virus Infections.

Authors:  Fátima Amaro; María P Sánchez-Seco; Ana Vázquez; Maria J Alves; Líbia Zé-Zé; Maria T Luz; Teodora Minguito; Jesús De La Fuente; Fernando De Ory
Journal:  Viruses       Date:  2019-02-20       Impact factor: 5.048

6.  Cerebrospinal fluid biomarker candidates associated with human WNV neuroinvasive disease.

Authors:  Christophe Fraisier; Anna Papa; Samuel Granjeaud; Rogier Hintzen; Byron Martina; Luc Camoin; Lionel Almeras
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

7.  Characterization and application of monoclonal antibodies specific to West Nile virus envelope protein.

Authors:  June Liu; Bohua Liu; Zhen Cao; Shingo Inoue; Kouichi Morita; Kegong Tian; Qingyu Zhu; George F Gao
Journal:  J Virol Methods       Date:  2008-11-05       Impact factor: 2.014
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.